Skip to main content
. 2020 Apr 10;320:495–510. doi: 10.1016/j.jconrel.2020.01.049

Fig. 1.

Fig. 1

The MD-AF4 method can help both drug developers and regulators alike to better characterize the physical properties of liposomal drug formulations. The method offers much more than simply size analysis, as highlighted in this diagram.